CLINICAL_TRIALS ClinicalTrials.gov record update

Assess Immunogenicity, Safety & Reactogenicity of a 4th Dose of GSK Biologicals' Tritanrix-HepB/Hib-MenAC at 15-24 m & of a Dose of Mencevax ACWY at 24-30 m in Subjects Primed With 3 Doses of Tritanrix-HepB/Hib-MenAC

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00136604
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:48.872527+00:00
Published At: 2018-09-17T00:00:00+00:00
Record Updated At: 2020-02-20
Results Posted At: 2018-09-17
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Whole Cell Pertussis", "Haemophilus Influenzae Type b", "Hepatitis B", "Diphtheria", "Tetanus", "Diphtheria-Tetanus-Pertussis-Hepatitis B-Haemophilus Influenzae Type b-Neisseria Meningitidis Vaccin"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-02-20"
protocolSection.identificationModule.nctId: "NCT00136604"
protocolSection.identificationModule.officialTitle: "Assess Immunogenicity, Safety \u0026 Reactogenicity of a 4th Dose of GSK Biologicals\u0027 Tritanrix-HepB/Hib-MenAC at 15-24 m \u0026 of a Dose of Mencevax ACWY at 24-30 m in Subjects Primed With 3 Doses of Tritanrix-HepB/Hib-MenAC"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2018-09-17"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.